DT-101 for Major Depressive Disorder
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
Recruiting
Phase 2
Interventional Study
Major Depressive Disorder (MDD)
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 118 (estimated)
- Sponsor
- Draig Therapeutics Ltd · Industry
Who this trial is looking for
This trial is looking for adults with Major Depressive Disorder who have had at least one previous episode of depression. Participants will receive either the study drug DT-101 or a placebo, and attend the clinic for health checks and questionnaires.
Are You a Good Fit for This Trial?
You may be able to join if
- I can read and understand the local language used in this study.
- I am between 18 and 75 years old.
- I have been diagnosed with recurrent depression.
You may not be able to join if
- I am pregnant or breastfeeding or plan to become pregnant during the study.
- I have an unstable medical condition.
- I have a significant neurological abnormality.
- I have a history of moderate or severe alcohol or drug use disorder in the past 6 months.
- I have a history of seizures.
- I am not able to follow the study requirements.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
In this study, researchers will learn more about a study drug called DT-101 in participants with Major Depressive Disorder (MDD), a form of depression. The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. A placebo looks the drug but contains no medicine. Subjects will attend the clinic for complete general health c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The participant is able to read, understand and communicate in the local language used at the study site, and is willing to provide written informed consent
* Male or female (assigned at birth, inclusive of all gender identities) participant must be 18 to 75 years of age, incl…
Contacts